The success (or failure) of a company is determined in large part by its products and how its technology differentiates those products from competitors’. This is especially true in the life sciences industry, where newcomers to the market and veterans alike need to be aware of potential pitfalls in navigating others’ proprietary technology while also protecting their own innovations
In this webinar, Dr. Alexander Augst, an attorney with Choate Hall & Stewart in Boston, will discuss:
Alexander Augst, advises clients in a wide variety of IP matters with a focus on procurement and commercialization of patent portfolios in a broad range of biomedical technologies. His background in academic technology transfer and his previous experience gained at an international law firm provide him with a deep understanding of the needs of a variety of clients, from academic institutions to start-ups and large corporations.
Prior to joining Choate, Dr. Augst was an associate at an international law firm where his practice focused on patent prosecution in the bio/pharma space and IP diligence in large commercial transactions.
Previously, Dr. Augst was an IP licensing manager at a major Boston area hospital where he performed business and IP analyses of inventions predominantly in the medical device space, prepared marketing materials, and negotiated and prepared a variety of agreements related to technology transactions.
Dr. Augst obtained his PhD from Imperial College London, where he developed computational models of blood flow in arteries, based on 3D ultrasound imaging. Subsequently, Dr. Augst was a post-doctoral researcher at Imperial College London, MIT and Harvard University, where he performed research in the area of cell- and tissue engineering and cell-biomaterial interactions.